Literature DB >> 11386315

Angiotensin-II-receptor inhibitors in pregnancy.

A Hinsberger, A M Wingen, P F Hoyer.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11386315     DOI: 10.1016/s0140-6736(00)04758-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Authors:  Chisa Shimada; Rina Akaishi; Kazutoshi Cho; Mamoru Morikawa; Yosuke Kaneshi; Takahiro Yamda; Hisanori Minakami
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

3.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

4.  Losartan induced fetal toxicity.

Authors:  Bonilla Nayar; Ashwani Singhal; Rajiv Aggarwal; Neena Malhotra
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

5.  Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists.

Authors:  Marine Lallemant; Sarah Prévost; François Nobili; Didier Riethmuller; Rajeev Ramanah; Marie-France Seronde; Nicolas Mottet
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Oct-Dec       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.